Udvalgte publikationer m.m. 


[Videnskabelige artikler]

Forsander, G., Bøgelund, M., Haas, J., Samuelsson, U., 2016. “Adolescent life with diabetes-Gender matters for level of distress. Experiences from the national TODS study“. Pediatr. Diabetes. doi:10.1111/pedi.12478

Bøgelund, M., Hagelund, L., Asmussen, M.B., 2017. “COPD-treating nurses’ preferences for inhaler attributes – a discrete choice experiment“. Curr. Med. Res. Opin. 33, 71–75. doi:10.1080/03007995.2016.1238353

Pavika J Lyngsie, Sandra Lopes & Jens Olsen. ”Incidence and cost of hypoglycemic events requiring medical assistance in a hospital setting in Denmark”. J. Comp. Eff. Res. (2016) 5(3), 239–247.

Rønborg S, Johnsen CR, Theilgaard S, Winther A, Hahn-Pedersen J, Andreasen JN, Olsen J. “Cost-minimization analysis of sublingual immunotherapy versus subcutaneous immunotherapy for house dust mite respiratory allergic disease in Denmark”. J Med Econ. 2016 Aug;19(8):735-41. doi: 10.3111/13696998.2016.1158718. Epub 2016 Mar 16.

Cleal, B., Panton, U.H., Willaing, I., Holt, Richard. I.G. “Diabetes and depression in Denmark 1996-2010: national data stratified by occupational status and annual income“. Diabetic Medicine. July 2016, DOI: 10.1111/dme.13187.

Jørgensen, T. R., Emborg, C., Dahlen, K., Bøgelund, M., Carlborg, A. “The effect of the medicine administration route on health-related quality of life: Results from a time trade-off survey in patients with bipolar disorder or schizophrenia in 2 Nordic countries“. BMC Psychiatry. 2016 Jul 16;16(1):244. doi: 10.1186/s12888-016-0930-6.

Cleal, B., Olesen, K., Hagelund, L., Willaing, I. “Willingness to Pay for Workplace Accommodations for People with Diabetes“. 827-P  – 11 Psychosocial, Behavioral Medicine. Saturday Jun 11, 2016 11:30 AM – 1:30 PM.

Cleal, B., Olesen, K., Hagelund, L., Willaing, I. “Willingness to Pay for Workplace Accommodations for People with Diabetes Compared with People with Unspecified Chronic Disease“. 857-P  – 11 Psychosocial, Behavioral Medicine. Saturday Jun 11, 2016 11:30 AM – 1:30 PM.

Feher MD, Brazier J, Schaper N, Vega-Hernandez G, Nikolajsen A, Bøgelund M. “Patients’ with type 2 diabetes willingness to pay for insulin therapy and clinical outcomes“. BMJ Open Diabetes Res Care. 2016 Apr 29;4(1):e000192. doi: 10.1136/bmjdrc-2016-000192. eCollection 2016. PMID: 27158518.

Olsen J, Jørgensen TR. “Revisiting the cost-effectiveness of universal HPV-vaccination in Denmark accounting for all potentially vaccine preventable HPV-related diseases in males and females”. Cost Effectiveness and Resource Allocation. 2015, 13:4. DOI 10.1186/s12962-015-0029-9

Sætterstrøm B, Olsen J, Johansen JD. ”Cost-of-illness of patients with contact dermatitis in Denmark”. Contact Dermatitis. Volume 71, Issue 3, September 2014, Pages: 154–161. doi: 10.1111/cod.12231

Harris S, Mamdani M, Galbo-Jørgensen CB, Bøgelund M, Gundgaard J, Groleau D “The effect of hypoglycemia on health-related quality of life: Canadian results from a multinational time trade-off survey” Can J Diabetes. 2014 Feb;38(1):45-52

Meinhardt U, Eiholzer U, Seitz L, Bøgelund M, Kappelgaard AM “Parent preference in Switzerland for easy-to-use attributes of growth hormone injection devices quantified by willingness to pay” Expert Rev Med Devices. 2014 Jan. Epub 2013 Dec 2

Evans M, Jensen HH, Boegelund M, Gundsgaard J, Chubb B, Khunti K. “Flexible insulin dosing improves health-related quality-of-life (HRQoL): a time trade-off survey” Journal of Medical Economics Vol. 16, No. 11, 2013, 1357–1365

Harris SB, Khunti K, Landin-Olsson M, Galbo-Jørgensen CB, Bøgelund M, Chubb B, Gundgaard J, Evans M. “Descriptions of health states associated with increasing severity and frequency of hypoglycemia a patient-level perspective”. Patient Preference and Adherence. September 2013

Evans M, Khunti K, Mamdani M, Galbo-Jørgensen CB, Gundgaard J, Bøgelund M, Harris S.” Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries.” Health Qual Life Outcomes. June 2013;11(1):90. [Epub ahead of print]

Joensen LE,  Tapager I, Willaing I. “Diabetes distress in Type 1 diabetes—a new measurement fit for purpose”. Diabetic Med.  2013 May 23. doi: 10.1111

Olsen J, Jørgensen TR, Rubek N. ”The Economic Burden of Head and Neck Cancers in Denmark”. International Journal of Otolaryngology and Head & Neck Surgery, 2013, 2, 103-109.

Mattsson LA, Ericsson A, Bøgelund M, Maamari R. “Women’s preferences toward attributes of local estrogen therapy for the treatment vaginal atrophy”. Maturitas. March 2013; 74(3): 259-263.

Olsen J, Jørgensen TR, Kofoed K, Larsen HK. ”Incidence and cost of anal, penile, vaginal and vulvar cancer in Denmark”. BMC Public Health. 2012 Dec 17;12:1082. doi: 10.1186/1471-2458-12-1082.

Rogvi S, Tapager I, Almdal TP, Schiøtz ML, Willaing I ‘Patient factors and glycaemic control–associations and explanatory power‘ Diabet Med. 2012 Oct;29(10):e382-9

Jendle J, Torffvit O, Ridderstråle M, Ericsson Å, Nilsen B, Bøgelund M. “Willingness to pay for diabetes drug therapy in type 2 diabetes patients: based on LEAD clinical programme results”. J Med Econ. 2012;15 Suppl 2:1-5.

Schiøtz M, Bøgelund M, Almdal T, Willaing I. “Discrete choice as a method for exploring education preferences in a Danish population of patients with type 2 diabetes”. Patient Educ Couns. 2012 May;87(2):217-25.

Schiøtz ML, Bøgelund M, Almdal T, Jensen BB, Willaing I. “Social support and self-management behaviour among patients with Type 2 diabetes”. Diabet Med. 2012 May;29(5):654-61.

Schiøtz M, Bøgelund M, Willaing I. “Challenges using online surveys in a Danish population of people with type 2 diabetes” Chronic Illn. 2012 Mar;8(1):56-63.

Bøgelund M, Vilsbøll T, Faber J, Henriksen JE, Gjesing RP, Lammert M. “Patient preferences for diabetes management among people with type 2 diabetes in Denmark – a discrete choice experiment”. Curr Med Res Opin. 2011 Nov;27(11):2175-83.

Lloyd A, Nafees B, Barnett AH, Heller S, Ploug UJ, Lammert M, Bøgelund M. “Willingness to pay for improvements in chronic long-acting insulin therapy in individuals with type 1 or type 2 diabetes mellitus”. Clin Ther. 2011 Sep;33(9):1258-67

Olsen J, Bonnevie B, Palmhøj-Nielsen C, Povlsen JV. ”Economic consequences of an increased number of patients on outgoing dialysis”. Scand J Urol Nephrol. 2010 Dec;44(6):452-8.

Jendle J, Torffvit O, Ridderstråle M, Lammert M, Ericsson A, Bøgelund M. “Willingness to pay for health improvements associated with anti-diabetes treatments for people with type 2 diabetes” Curr Med Res Opin. 2010 Apr;26(4):917-23.

Olsen J, Jepsen MR. “Human papillomavirus transmission and cost-effectiveness of introducing quadrivalent HPV vaccination in Denmark“. Int J Technol Assess Health Care. 2010 Apr;26(2):183-91.

Usher C, Tilson L, Olsen J, Jepsen M, Walsh C, Barry M. “Cost-effectiveness of human papillomavirus vaccine in reducing the risk of cervical cancer in Ireland due to HPV types 16 and 18 using a transmission dynamic model”. Vaccine. 2008 Oct 16;26(44):5654-61.


Z Hussein, M Evans, HH Jensen, M Bøgelund, J Gundgaard, B Chubb, A Nazeri, K Khunti: Flexible Insulin Dosing Improves Health-related Quality of Life (HRQoL) in a Basal Only Treatment Regimen A Time Trade-off Survey. Poster presented at the  the National Diabetes Institute (NADI) meeting, 23-27 October 2012, Malaysia.

Tapager I W,Jensen H H, Mønsted C, Bøgelund M. “Optimizing discrete choice experiment designs using simulations” Poster presented at the ISPOR 15th Annual European Congress, 3–7 November 2012, Berlin, Germany.

Haas J, Bogelund M, Short C, Marcus C, Carlsson A, Samuelsson U, Karlsson AK,  Forsander G. “Situation-driven-difficulties-in-controlling-diabetes-among-adolescents-with-type-1-diabetes”. Poster presented at ISPAD, October 10-12, 2012, Istanbul, Turkey.

Jendle J, Torffvit O, Ridderstråle M, Ericsson Å, Nilsen B, Bøgelund M. “Willingness to pay for diabetes drug therapy based on meta-analysis results”. Poster presented at the ISPOR 13th Annual European Congress, 6–9 November 2010, Prague, Czech Republic.